volume 39, issue 5, P631-638 2013
DOI: 10.1590/s1677-5538.ibju.2013.05.04
View full text
Sign up to set email alerts

Abstract: Objectives: Although the glycoprotein group tumor marker CA 19-9 has been detected in both serum and urine of bladder cancer patients, information about their comparative role in screening of low grade transitional cell carcinoma (LGTCC) and high grade transitional cell carcinoma (HGTCC) is rare. Materials and Methods: In this study we measured both the urinary and serum levels of CA 19-9 in 35 LGTCC and 20 HGTCC patients by ELISA and determined the cut off value of both urinary and serum CA 19-9 levels by re…

Expand abstract